Iressa as Second Line Therapy in Advanced NSCLC-Asia
Clinical trial NCT00478049 · COMPLETED
Trial details
- NCT number
- NCT00478049
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2007-05-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.